Related references
Note: Only part of the references are listed.MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion
Lars Maegdefessel et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
被撤回的出版物: AMPKα2 Deletion Exacerbates Neointima Formation by Upregulating Skp2 in Vascular Smooth Muscle Cells (Retracted article. See vol. 129, 2021)
Ping Song et al.
CIRCULATION RESEARCH (2011)
Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice
Debra L. Rateri et al.
CIRCULATION RESEARCH (2011)
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
Martina Lukasova et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
Pathophysiology and epidemiology of abdominal aortic aneurysms
Ian M. Nordon et al.
NATURE REVIEWS CARDIOLOGY (2011)
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Daniel F. Egan et al.
SCIENCE (2011)
Reduction of AMP-Activated Protein Kinase α2 Increases Endoplasmic Reticulum Stress and Atherosclerosis In Vivo
Yunzhou Dong et al.
CIRCULATION (2010)
AMPKα2 Deletion Causes Aberrant Expression and Activation of NAD(P)H Oxidase and Consequent Endothelial Dysfunction In Vivo Role of 26S Proteasomes
Shuangxi Wang et al.
CIRCULATION RESEARCH (2010)
Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice
Alan Daugherty et al.
CLINICAL SCIENCE (2010)
Hyperglycemia limits experimental aortic aneurysm progression
Noriyuki Miyama et al.
JOURNAL OF VASCULAR SURGERY (2010)
Redox Regulation of the AMP-Activated Protein Kinase
Yingying Han et al.
PLOS ONE (2010)
Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation
David Bungard et al.
SCIENCE (2010)
Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease
Monica M. Dua et al.
SURGERY (2010)
In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I (Publication with Expression of Concern. See vol. 72, pg. 1037, 2023)
Shuangxi Wang et al.
DIABETES (2009)
Identification of the Serine 307 of LKB1 as a Novel Phosphorylation Site Essential for Its Nucleocytoplasmic Transport and Endothelial Cell Angiogenesis
Zhonglin Xie et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms
Kimio Satoh et al.
NATURE MEDICINE (2009)
Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain
Shuangxi Wang et al.
CARDIOVASCULAR RESEARCH (2008)
Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide
Miao Zhang et al.
CIRCULATION RESEARCH (2008)
The role of the renin-angiotensin system in aortic aneurysmal diseases
Hong Lu et al.
CURRENT HYPERTENSION REPORTS (2008)
Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions
Jonathan Golledge et al.
EUROPEAN HEART JOURNAL (2008)
Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure
Shuangxi Wang et al.
HYPERTENSION (2008)
Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells (Publication with Expression of Concern. See vol. 294, pg. 10027, 2019) (Withdrawn Publication. See vol. 295, pg. 670, 2020)
Junhua Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
被撤回的出版物: Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo (Retracted article. See vol. 294, pg. 10742, 2019)
Hyoung Chul Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Extracellular control of TGFβ signalling in vascular development and disease
Peter ten Dijke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor
Myung-Jin Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 Adipocytes - A role for oxidant stress (Publication with Expression of Concern. See vol. 294, pg. 10025, 2019) (Withdrawn Publication. See vol. 295, pg. 667, 2020)
Zhibo An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm
Faisal Aziz et al.
ANNALS OF VASCULAR SURGERY (2007)
Abdominal aortic aneurysm - Pathogenesis and implications for management
Jonathan Golledge et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice
Manesh Thomas et al.
CIRCULATION (2006)
Biomechanical determinants of abdominal aortic aneurysm rupture
DA Vorp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice
D Gavrila et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Association of osteoprotegerin with human abdominal aortic aneurysm progression
CS Moran et al.
CIRCULATION (2005)
Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis
YX Wang et al.
CIRCULATION (2005)
Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappa B and activator protein 1 in a redox-sensitive manner
M Browatzki et al.
JOURNAL OF VASCULAR RESEARCH (2005)
Mouse models of abdominal aortic aneurysms
A Daugherty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice
G Matute-Bello et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation
D Nagata et al.
CIRCULATION (2004)
Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment
NL Benowitz
PROGRESS IN CARDIOVASCULAR DISEASES (2003)
The AMP-activated protein kinase alpha 2 catalytic subunit controls whole-body insulin sensitivity
B Viollet et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms
GM Longo et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts -: A cellular mechanism for release of TGF-β from bone matrix
SL Dallas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The regulation of AMP-activated protein kinase by H2O2.
SL Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle
J Mu et al.
MOLECULAR CELL (2001)
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
R Pyo et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)